Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what plans NHS England has to protect patients with covid-19 from the increased risk in that group of potentially fatal venous thromboembolism.
As COVID-19 is a new disease, there is no high quality evidence to guide clinical management in protecting patients with the disease from the increased risk of thromboembolism. NHS England and NHS Improvement are urging clinicians to support research which may evaluate methods to prevent or reduce harm from thromboembolism in the context of COVID-19.
NHS England and NHS Improvement are not planning to publish clinical guidance it commissioned in relation to venous thromboembolism in patients with COVID-19. NHS England and NHS Improvement are engaging with other organisations and professional bodies and looking to them to publish the guidance as soon as possible.